Roundhill Investments Launches GLP-1 & Weight Loss ETF
Roundhill Investments Launches GLP-1 & Weight Loss ETF
朗德希爾投資推出 GLP-1 和減肥ETF
OZEM provides exposure to the rapidly growing weight loss management market, which is expected to reach $100 billion by 2030.
OZEM爲快速增長的減肥管理市場提供了機會，預計到2030年減肥管理市場將達到1000億美元。
NEW YORK, May 21, 2024 /PRNewswire/ -- Roundhill Investments, an ETF sponsor focused on innovative financial products, is pleased to announce the launch of the Roundhill GLP-1 & Weight Loss ETF (OZEM), which began trading on Nasdaq today. OZEM is the world's first ETF focused exclusively on the rapidly growing sector of GLP-1 receptor agonists and other weight management drugs.
紐約，2024年5月21日 /PRNewswire/ — 專注於創新金融產品的ETF贊助商Roundhill Investments欣然宣佈推出朗德希爾 GLP-1 和減肥ETF（OZEM），該ETF於今天在納斯達克開始交易。OZEM 是世界上第一隻專注於快速增長的 GLP-1 受體激動劑和其他體重管理藥物領域的ETF。